McMaster Health Sciences @machealthsci · 15 Aug 2025
Omalizumab and remibrutinib are the most effective drugs for refractory chronic urticaria, finds study. Led by Alexandro Chu, @MacDeptMed research assistant, the meta-analysis compared the benefits and harms of systemic treatments for chronic urticaria. https://t.co/pj6uNtA6Sm
1 157Views
3Likes
1Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
0.51×vs 10K–100K median2 259 views is typical
8.99%Reachviews ÷ followers
0.35%Engagement rateof viewers reacted